Search Follow us

Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Director

Sean Conroy

Sean Conroy
Associate Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Director

Maxim Jacobs

Maxim Jacobs
Managing Partner, North America

Dr Susie Jana

Dr Susie Jana
Director

Alice Nettleton

Alice Nettleton
Associate Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Director

Dr John Savin

Dr John Savin
Analyst

Andy Smith

Andy Smith

Briana Warschun

Briana Warschun
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Associate Director

By region

Recent initiations

ADL Bionatur Solutions OSE Immunotherapeutics
CASI Pharmaceuticals Auris Medical Holding
MGC Pharmaceuticals BioLargo

Recent QuickViews

TruScreen

Fast and objective cervical cancer screening

Pharmaceutical & healthcare | published 06/12/2018
Oxford Immunotec

Not your usual diagnostics company

Pharmaceutical & healthcare | published 30/11/2018
Vectura

Not pausing for breath

Pharmaceutical & healthcare | published 26/11/2018
BTG

The BTG acquisition: Small fly, big ointment

Pharmaceutical & healthcare | published 22/11/2018

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

Nuevolution

Clinical development in 2019

Update | Pharmaceutical & healthcare | 10/12/2018

Nuevolution’s drug discovery platform (Chemetics) continues to receive external validation, with Amgen opting in for another oncology programme from…

Sunesis Pharmaceuticals

ASH 2018: 50mg cohort on last patient

Update | Pharmaceutical & healthcare | 10/12/2018

The company provided an update at the American Society of Hematology (ASH) 2018 meeting in December on its ongoing dose-escalation study of vecabrutinib…

CASI Pharmaceuticals

Evomela approved in China

Update | Pharmaceutical & healthcare | 10/12/2018

CASI announced that it has received approval in China for Evomela. The drug is a formulation of melphalan hydrochloride used in the treatment of multiple…

ADL Bionatur Solutions

Value-added biotech manufacturing

Initiation | Pharmaceutical & healthcare | 10/12/2018

ADL Bionatur Solutions (ADL-BS) was formed through the reverse takeover in April 2018 of contract manufacturing (CMO) and active pharmaceutical ingredient…

Atossa Genetics

Multiple opportunities to address breast health

Outlook | Pharmaceutical & healthcare | 07/12/2018

Atossa Genetics’s endoxifen programs are advancing in their respective breast health programs. The firm recently reported positive safety data from…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies